Eintrag weiter verarbeiten
Controversies in the Management of Endometrial Carcinoma
Gespeichert in:
| Zeitschriftentitel: | Obstetrics and Gynecology International |
|---|---|
| Personen und Körperschaften: | , |
| In: | Obstetrics and Gynecology International, 2010, 2010, S. 1-16 |
| Format: | E-Article |
| Sprache: | Englisch |
| veröffentlicht: |
Hindawi Limited
|
| Schlagwörter: |
| author_facet |
Zhang, Ying Wang, Jian Zhang, Ying Wang, Jian |
|---|---|
| author |
Zhang, Ying Wang, Jian |
| spellingShingle |
Zhang, Ying Wang, Jian Obstetrics and Gynecology International Controversies in the Management of Endometrial Carcinoma Obstetrics and Gynecology |
| author_sort |
zhang, ying |
| spelling |
Zhang, Ying Wang, Jian 1687-9589 1687-9597 Hindawi Limited Obstetrics and Gynecology http://dx.doi.org/10.1155/2010/862908 <jats:p>Endometrial carcinoma is the most common type of female genital tract malignancy. Although endometrial carcinoma is a low grade curable malignancy, the condition of the disease can range from excellent prognosis with high curability to aggressive disease with poor outcome. During the last 10 years many researches have provided some new valuable data of optimal treatments for endometrial carcinoma. Progression in diagnostic imaging, radiation delivery systems, and systemic therapies potentially can improve outcomes while minimizing morbidity. Firstly, total hysterectomy and bilateral salphingo-oophorectomy is the primary operative procedure. Pelvic lymhadenectomy is performed in most centers on therapeutic and prognostic grounds and to individualize adjuvant treatment. Women with endometrial carcinoma can be readily segregated intraoperatively into “low-risk” and “high-risk” groups to better identify those women who will most likely benefit from thorough lymphadenectomy. Secondly, adjuvant therapies have been proposed for women with endometrial carcinoma postoperatively. Postoperative irradiation is used to reduce pelvic and vaginal recurrences in high risk cases. Chemotherapy is emerging as an important treatment modality in advanced endometrial carcinoma. Meanwhile the availability of new hormonal and biological agents presents new opportunities for therapy.</jats:p> Controversies in the Management of Endometrial Carcinoma Obstetrics and Gynecology International |
| doi_str_mv |
10.1155/2010/862908 |
| facet_avail |
Online Free |
| format |
ElectronicArticle |
| fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE1NS8yMDEwLzg2MjkwOA |
| id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE1NS8yMDEwLzg2MjkwOA |
| institution |
DE-Zi4 DE-Gla1 DE-15 DE-Pl11 DE-Rs1 DE-14 DE-105 DE-Ch1 DE-L229 DE-D275 DE-Bn3 DE-Brt1 DE-Zwi2 DE-D161 |
| imprint |
Hindawi Limited, 2010 |
| imprint_str_mv |
Hindawi Limited, 2010 |
| issn |
1687-9589 1687-9597 |
| issn_str_mv |
1687-9589 1687-9597 |
| language |
English |
| mega_collection |
Hindawi Limited (CrossRef) |
| match_str |
zhang2010controversiesinthemanagementofendometrialcarcinoma |
| publishDateSort |
2010 |
| publisher |
Hindawi Limited |
| recordtype |
ai |
| record_format |
ai |
| series |
Obstetrics and Gynecology International |
| source_id |
49 |
| title |
Controversies in the Management of Endometrial Carcinoma |
| title_unstemmed |
Controversies in the Management of Endometrial Carcinoma |
| title_full |
Controversies in the Management of Endometrial Carcinoma |
| title_fullStr |
Controversies in the Management of Endometrial Carcinoma |
| title_full_unstemmed |
Controversies in the Management of Endometrial Carcinoma |
| title_short |
Controversies in the Management of Endometrial Carcinoma |
| title_sort |
controversies in the management of endometrial carcinoma |
| topic |
Obstetrics and Gynecology |
| url |
http://dx.doi.org/10.1155/2010/862908 |
| publishDate |
2010 |
| physical |
1-16 |
| description |
<jats:p>Endometrial carcinoma is the most common type of female genital tract malignancy. Although endometrial carcinoma is a low grade curable malignancy, the condition of the disease can range from excellent prognosis with high curability to aggressive disease with poor outcome. During the last 10 years many researches have provided some new valuable data of optimal treatments for endometrial carcinoma. Progression in diagnostic imaging, radiation delivery systems, and systemic therapies potentially can improve outcomes while minimizing morbidity. Firstly, total hysterectomy and bilateral salphingo-oophorectomy is the primary operative procedure. Pelvic lymhadenectomy is performed in most centers on therapeutic and prognostic grounds and to individualize adjuvant treatment. Women with endometrial carcinoma can be readily segregated intraoperatively into “low-risk” and “high-risk” groups to better identify those women who will most likely benefit from thorough lymphadenectomy. Secondly, adjuvant therapies have been proposed for women with endometrial carcinoma postoperatively. Postoperative irradiation is used to reduce pelvic and vaginal recurrences in high risk cases. Chemotherapy is emerging as an important treatment modality in advanced endometrial carcinoma. Meanwhile the availability of new hormonal and biological agents presents new opportunities for therapy.</jats:p> |
| container_start_page |
1 |
| container_title |
Obstetrics and Gynecology International |
| container_volume |
2010 |
| format_de105 |
Article, E-Article |
| format_de14 |
Article, E-Article |
| format_de15 |
Article, E-Article |
| format_de520 |
Article, E-Article |
| format_de540 |
Article, E-Article |
| format_dech1 |
Article, E-Article |
| format_ded117 |
Article, E-Article |
| format_degla1 |
E-Article |
| format_del152 |
Buch |
| format_del189 |
Article, E-Article |
| format_dezi4 |
Article |
| format_dezwi2 |
Article, E-Article |
| format_finc |
Article, E-Article |
| format_nrw |
Article, E-Article |
| _version_ |
1792324122504593423 |
| geogr_code |
not assigned |
| last_indexed |
2024-03-01T11:44:40.173Z |
| geogr_code_person |
not assigned |
| openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Controversies+in+the+Management+of+Endometrial+Carcinoma&rft.date=2010-01-01&genre=article&issn=1687-9597&volume=2010&spage=1&epage=16&pages=1-16&jtitle=Obstetrics+and+Gynecology+International&atitle=Controversies+in+the+Management+of+Endometrial+Carcinoma&aulast=Wang&aufirst=Jian&rft_id=info%3Adoi%2F10.1155%2F2010%2F862908&rft.language%5B0%5D=eng |
| SOLR | |
| _version_ | 1792324122504593423 |
| author | Zhang, Ying, Wang, Jian |
| author_facet | Zhang, Ying, Wang, Jian, Zhang, Ying, Wang, Jian |
| author_sort | zhang, ying |
| container_start_page | 1 |
| container_title | Obstetrics and Gynecology International |
| container_volume | 2010 |
| description | <jats:p>Endometrial carcinoma is the most common type of female genital tract malignancy. Although endometrial carcinoma is a low grade curable malignancy, the condition of the disease can range from excellent prognosis with high curability to aggressive disease with poor outcome. During the last 10 years many researches have provided some new valuable data of optimal treatments for endometrial carcinoma. Progression in diagnostic imaging, radiation delivery systems, and systemic therapies potentially can improve outcomes while minimizing morbidity. Firstly, total hysterectomy and bilateral salphingo-oophorectomy is the primary operative procedure. Pelvic lymhadenectomy is performed in most centers on therapeutic and prognostic grounds and to individualize adjuvant treatment. Women with endometrial carcinoma can be readily segregated intraoperatively into “low-risk” and “high-risk” groups to better identify those women who will most likely benefit from thorough lymphadenectomy. Secondly, adjuvant therapies have been proposed for women with endometrial carcinoma postoperatively. Postoperative irradiation is used to reduce pelvic and vaginal recurrences in high risk cases. Chemotherapy is emerging as an important treatment modality in advanced endometrial carcinoma. Meanwhile the availability of new hormonal and biological agents presents new opportunities for therapy.</jats:p> |
| doi_str_mv | 10.1155/2010/862908 |
| facet_avail | Online, Free |
| format | ElectronicArticle |
| format_de105 | Article, E-Article |
| format_de14 | Article, E-Article |
| format_de15 | Article, E-Article |
| format_de520 | Article, E-Article |
| format_de540 | Article, E-Article |
| format_dech1 | Article, E-Article |
| format_ded117 | Article, E-Article |
| format_degla1 | E-Article |
| format_del152 | Buch |
| format_del189 | Article, E-Article |
| format_dezi4 | Article |
| format_dezwi2 | Article, E-Article |
| format_finc | Article, E-Article |
| format_nrw | Article, E-Article |
| geogr_code | not assigned |
| geogr_code_person | not assigned |
| id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE1NS8yMDEwLzg2MjkwOA |
| imprint | Hindawi Limited, 2010 |
| imprint_str_mv | Hindawi Limited, 2010 |
| institution | DE-Zi4, DE-Gla1, DE-15, DE-Pl11, DE-Rs1, DE-14, DE-105, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161 |
| issn | 1687-9589, 1687-9597 |
| issn_str_mv | 1687-9589, 1687-9597 |
| language | English |
| last_indexed | 2024-03-01T11:44:40.173Z |
| match_str | zhang2010controversiesinthemanagementofendometrialcarcinoma |
| mega_collection | Hindawi Limited (CrossRef) |
| physical | 1-16 |
| publishDate | 2010 |
| publishDateSort | 2010 |
| publisher | Hindawi Limited |
| record_format | ai |
| recordtype | ai |
| series | Obstetrics and Gynecology International |
| source_id | 49 |
| spelling | Zhang, Ying Wang, Jian 1687-9589 1687-9597 Hindawi Limited Obstetrics and Gynecology http://dx.doi.org/10.1155/2010/862908 <jats:p>Endometrial carcinoma is the most common type of female genital tract malignancy. Although endometrial carcinoma is a low grade curable malignancy, the condition of the disease can range from excellent prognosis with high curability to aggressive disease with poor outcome. During the last 10 years many researches have provided some new valuable data of optimal treatments for endometrial carcinoma. Progression in diagnostic imaging, radiation delivery systems, and systemic therapies potentially can improve outcomes while minimizing morbidity. Firstly, total hysterectomy and bilateral salphingo-oophorectomy is the primary operative procedure. Pelvic lymhadenectomy is performed in most centers on therapeutic and prognostic grounds and to individualize adjuvant treatment. Women with endometrial carcinoma can be readily segregated intraoperatively into “low-risk” and “high-risk” groups to better identify those women who will most likely benefit from thorough lymphadenectomy. Secondly, adjuvant therapies have been proposed for women with endometrial carcinoma postoperatively. Postoperative irradiation is used to reduce pelvic and vaginal recurrences in high risk cases. Chemotherapy is emerging as an important treatment modality in advanced endometrial carcinoma. Meanwhile the availability of new hormonal and biological agents presents new opportunities for therapy.</jats:p> Controversies in the Management of Endometrial Carcinoma Obstetrics and Gynecology International |
| spellingShingle | Zhang, Ying, Wang, Jian, Obstetrics and Gynecology International, Controversies in the Management of Endometrial Carcinoma, Obstetrics and Gynecology |
| title | Controversies in the Management of Endometrial Carcinoma |
| title_full | Controversies in the Management of Endometrial Carcinoma |
| title_fullStr | Controversies in the Management of Endometrial Carcinoma |
| title_full_unstemmed | Controversies in the Management of Endometrial Carcinoma |
| title_short | Controversies in the Management of Endometrial Carcinoma |
| title_sort | controversies in the management of endometrial carcinoma |
| title_unstemmed | Controversies in the Management of Endometrial Carcinoma |
| topic | Obstetrics and Gynecology |
| url | http://dx.doi.org/10.1155/2010/862908 |